Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)

China · Delayed Price · Currency is CNY

8.19

+0.08 (0.99%)

Sep 30, 2026, 3:00 PM CST

Market Cap	4.09B +31.2%
Revenue (ttm)	1.84B -3.1%
Net Income	27.40M -58.7%
EPS	0.05 -58.3%
Shares Out	534.07M
PE Ratio	163.65
Forward PE	n/a
Dividend	0.07 (0.85%)
Ex-Dividend Date	Jun 17, 2026

Volume	59,711,436
Open	8.07
Previous Close	8.11
Day's Range	8.02 - 8.60
52-Week Range	4.33 - 12.77
Beta	0.62
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2026

About SHA:600613

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sales of pharmaceuticals in China and internationally. The company offers patented anti-tumor drugs; topical antibacterial series; products for hypertension, hyperlipidemia, and hyperglycemia chronic diseases; classic Chinese medicine cough relief series; classic tonic product series; Miao medicine for strengthening muscles and bones series; and magical doll medicine series. It also provides tooth... [Read more]

Industry Drug Manufacturers - General

Sector Healthcare

Founded 1992

Employees 1,196

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600613

Full Company Profile

Financial Performance

In 2025, SHA:600613's revenue was 1.95 billion, a decrease of -4.71% compared to the previous year's 2.05 billion. Earnings were 38.24 million, a decrease of -46.43%.

Financial Statements